Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Oslo - Delayed Quote NOK

Lifecare AS (LIFE.OL)

Compare
9.80
-0.80
(-7.55%)
At close: April 4 at 4:25:21 PM GMT+2
Loading Chart for LIFE.OL
  • Previous Close 10.60
  • Open 10.05
  • Bid 9.80 x --
  • Ask 9.94 x --
  • Day's Range 9.80 - 10.65
  • 52 Week Range 9.80 - 57.70
  • Volume 14,595
  • Avg. Volume 31,305
  • Market Cap (intraday) 155.35M
  • Beta (5Y Monthly) -0.36
  • PE Ratio (TTM) --
  • EPS (TTM) -4.59
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 30.50

Lifecare AS engages in the research and development of medical sensors for health monitoring in Norway. The company develops Sencell, a micro sensor for monitoring glucose levels in patients with diabetes. It manufactures and develops nanostrain biosensors for measuring pressure and temperature in live tissue. Lifecare AS was founded in 2006 and is based in Bergen, Norway.

www.lifecare.no

29

Full Time Employees

December 31

Fiscal Year Ends

Recent News: LIFE.OL

View More

Performance Overview: LIFE.OL

Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is OBX Total Return Index (OBX.OL) .

YTD Return

LIFE.OL
20.00%
OBX Total Return Index (OBX.OL)
0.27%

1-Year Return

LIFE.OL
82.45%
OBX Total Return Index (OBX.OL)
5.53%

3-Year Return

LIFE.OL
55.64%
OBX Total Return Index (OBX.OL)
15.40%

5-Year Return

LIFE.OL
59.84%
OBX Total Return Index (OBX.OL)
102.14%

Compare To: LIFE.OL

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: LIFE.OL

View More

Valuation Measures

Annual
As of 4/4/2025
  • Market Cap

    155.35M

  • Enterprise Value

    104.60M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    62.67

  • Price/Book (mrq)

    2.09

  • Enterprise Value/Revenue

    42.19

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -53.26%

  • Return on Equity (ttm)

    -103.60%

  • Revenue (ttm)

    9.67M

  • Net Income Avi to Common (ttm)

    -71.76M

  • Diluted EPS (ttm)

    -4.59

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    61.62M

  • Total Debt/Equity (mrq)

    14.68%

  • Levered Free Cash Flow (ttm)

    -36.94M

Research Analysis: LIFE.OL

View More

Company Insights: LIFE.OL

Research Reports: LIFE.OL

View More

People Also Watch